STERIS is a global leader in infection prevention, contamination control, surgical technologies, and more.
STERIS is the world’s pre-eminent infection prevention, decontamination, and surgical and critical care company, with a long list of first-to-market products and industry-leading service innovations and thousands of customers in more than 60 countries.
While the corporation was founded as Innovative Medical Technologies in 1985 and renamed STERIS in 1987, our history dates back to 1894 with the founding of American Sterilizer Company, a long-time, global leading innovator of sterilization products.
Today, through a series of strategic acquisitions and continual innovation of new products, STERIS holds one of the broadest portfolios of products in the industry. It stands at the forefront of efforts to prevent infection and contamination in healthcare and pharmaceutical environments, and is broadening its reach with products to meet the needs of defense and industrial markets.

Company Growth (employees)
Mentor, US
Size (employees)
12,000 (est)-14%
STERIS was founded in 1987 and is headquartered in Mentor, US

STERIS Office Locations

STERIS has an office in Mentor
Mentor, US (HQ)
5960 Heisley Rd
Mentor, US
9260 Progress Pkwy

STERIS Financials and Metrics

STERIS Financials

STERIS's revenue was reported to be $2.6 b in FY, 2017

Revenue (Q1, 2018)

608 m

Gross profit (Q1, 2018)

256.1 m

Gross profit margin (Q1, 2018), %


Net income (Q1, 2018)

58.2 m

EBIT (Q1, 2018)

86.3 m

Market capitalization (13-Nov-2017)

7.5 b

Cash (30-Jun-2017)

294.8 m
STERIS's current market capitalization is $7.5 b.
USDFY, 2014FY, 2015FY, 2016FY, 2017


1.6 b1.9 b2.2 b2.6 b

Revenue growth, %


Cost of goods sold

972.6 m1.1 b1.3 b1.6 b

Gross profit

649.6 m774.3 m895.5 m1 b
USDQ3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018


618.7 m638.4 m646.4 m646.8 m608 m

Cost of goods sold

380.5 m398.4 m398.5 m389.2 m351.8 m

Gross profit

238.2 m240 m247.9 m257.6 m256.1 m

Gross profit Margin, %

USDFY, 2014FY, 2015FY, 2016FY, 2017


152.8 m167.7 m248.8 m282.9 m

Accounts Receivable

313.7 m325.3 m471.5 m483.5 m


37 m35 m59.4 m197.8 m

Current Assets

674.7 m720.4 m972.5 m1 b
USDQ3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018


231.4 m242.4 m254.4 m264.9 m294.8 m

Accounts Receivable

440.9 m439.8 m441.3 m443.7 m455.6 m


208.3 m209.6 m209.9 m209.7 m217.4 m

Current Assets

965.7 m945.9 m956.2 m970.3 m1 b
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

129.4 m135.1 m110.8 m110 m

Accounts Receivable

(29 m)(2.8 m)(31.6 m)(48.1 m)

Accounts Payable

19.4 m(3.1 m)5.2 m6.9 m

Cash From Operating Activities

209.6 m246 m81.2 m424.1 m
USDQ3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Net Income

20 m48.4 m88.9 m84.6 m58.2 m

Accounts Receivable

(3.1 m)23.2 m11.7 m(213 k)32 m

Accounts Payable

(17.9 m)(13.2 m)(17 m)(5.8 m)(10.2 m)

Cash From Operating Activities

104.6 m80.3 m188.5 m289.4 m80.7 m
Y, 2017

Financial Leverage

1.7 x
Show all financial metrics

STERIS Operating Metrics

FY, 2016

Patents (foreign)

1.1 k

Patents (US)


Patents Pending

Show all operating metrics

STERIS Market Value History

STERIS Revenue Breakdown

STERIS Median Salaries

Source: 46 public H-1B filings from STERIS

STERIS's Web-traffic and Trends

STERIS Online and Social Media Presence

STERIS News and Updates

Food Irradiation Market 2017 Global Analysis, Opportunities and Forecast To 2022

Global Food Irradiation Market is expected to reach $194.97 million by 2022 at a CAGR of 4.3% during the forecast period 2015 to 2022 Posted via Industry Today. Follow us on Twitter @IndustryToday

Chemical Indicator Inks Market to hit $78.3mn by 2024

Global Chemical Indicator Inks Market share is highly consolidated with major industry participants are Tempil, North American Science Associates (NAMSA), 3M, Terragene SA and STERIS are major industry players. Other prominent industry contributors are NiGK, Riken Chemical, Crosstex and gke Gmbh. P…

STERIS Company Life and Culture

You may also be interested in